Abstract

Background Antimicrobial resistance among community-acquired uropathogens is an emerging concern over the past decades that warrants a continuing reevaluation of the appropriateness of recommended empiric antimicrobial regimens for treatment of urinary tract infections (UTIs). Aims To describe the microbial spectrum and resistance profile of community-acquired uropathogens and predictors of isolation of resistant strains. Methods Between October 2017 and June 2019, individuals who visited the outpatient clinics for diagnosis of UTIs or screening of asymptomatic bacteriuria were included in the study if they were tested for urine culture in one of the three main medical diagnostic laboratories of Mashhad, Iran. The standard disk diffusion antimicrobial susceptibility testing was used, with the Clinical and Laboratory Standards Institute (CLSI) threshold cutoffs for susceptibility of isolated uropathogens. Results Three hundred thirty cases were included with a median age of 47 years. Two hundred seventy-six (83.6%) were female. The most common isolated uropathogens were Escherichia coli in 201 (60.9%) cases and Klebsiella species in 46 (13.9%) cases. E. coli isolates showed the highest rates of susceptibility to nitrofurantoin (89.3%), cefixime (75%), and gentamicin (72.4%). Exposure to antibiotics in the past 3 months was a predictor of resistance to ciprofloxacin (OR: 2.8, 95% CI: 1.33–6.28), and older age was a predictor of resistance to TMP-SMX (OR: 2.1, 95% CI: 1.07–3.97) among E. coli isolates. Conclusion. E. coli and Klebsiella species accounted for about two-thirds of community-acquired uropathogens. In regard to the high susceptibility rates, nitrofurantoin was identified as the first-choice agent for empiric treatment of community-acquired cystitis, while cefixime and gentamicin might be the second-choice alternatives. Ciprofloxacin and TMP-SMX, on the other hand, cannot be considered appropriate agents for empiric therapy of community-acquired UTIs, particularly in those who had exposure to antibiotics in the past 3 months and the elderly.

Highlights

  • Urinary tract infection (UTI) is the most common bacterial infection encountered in the ambulatory care setting [1], with a lifetime incidence of 50–60% in adult women [2]

  • Growth of bacteria on urine culture supports the diagnosis of UTIs, and susceptibility testing is Journal of Environmental and Public Health considered essential to ensuring appropriate antimicrobial treatment [4]

  • Urine culture was requested for diagnosis of symptomatic UTIs in 240 (82.2%) of 292 cases and screening of asymptomatic bacteriuria in 52 cases (17.8%)

Read more

Summary

Introduction

Urinary tract infection (UTI) is the most common bacterial infection encountered in the ambulatory care setting [1], with a lifetime incidence of 50–60% in adult women [2]. Emergence of antimicrobial resistance among uropathogens, those causing community-acquired UTIs, is one of the most important factors impacting the management of UTIs over the past decades [3]. In the appropriate clinical setting, the diagnosis of UTIs is typically made using both urinalysis and urine culture with susceptibility testing. Empiric therapy is considered the standard management approach of acute community-acquired uncomplicated cystitis [1, 5, and 6]. Antimicrobial resistance among community-acquired uropathogens is an emerging concern over the past decades that warrants a continuing reevaluation of the appropriateness of recommended empiric antimicrobial regimens for treatment of urinary tract infections (UTIs). Ciprofloxacin and TMP-SMX, on the other hand, cannot be considered appropriate agents for empiric therapy of community-acquired UTIs, in those who had exposure to antibiotics in the past 3 months and the elderly

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.